EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

At the recent European Haematology Association (EHA) Annual Congress 2018, Myeloma Patients Europe (MPE) and Video Journal of Hematological Oncology (VJHemOnc), filmed an interview with Dr Michael Hudecek (University of Würzburg, Germany) on the Horizon2020 CARAMBA project. The video was recorded in English and has now been translated into four additional languages: French, German, Spanish and Italian.

MPE is collaborating with a consortium of European partners on CARAMBA to study an innovative new treatment for myeloma called chimeric antigen receptor T cell (CAR-T) therapy. In this video, Michael explains CAR-T cell therapy and the Horizon2020 CARAMBA project in more detail.
To activate the subtitles in your preferred language, please go to “settings”, as highlighted in the image below, and select the relevant language:

 

You can view the video below. For further information about Horizon2020 CARMABA, please visit: https://www.caramba-cart.eu/
Alternatively, please email info@mpeurope.org if you have any further questions about the project.

 







Recent news

» Horizon2020 CARAMBA Myeloma Pipeline information sheet now available in five languages

» The FDA approves the first anti-BCMA CAR-T Cell Therapy for myeloma, idecabtagene vicleucel (Abecma)

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.